# Kidney Cancer - What Sets the Subtypes Apart

## Research question

Which expression and pathway patterns distinguish the three renal tumor subtypes in this historical cohort?

Find a manageable public dataset with renal subtype labels, assess sample comparability, and investigate expression and pathway differences supported by those data. The selected deliverable is the second reviewed attempt (7-2).

## Data and comparison design

Interpret subtype contrasts alongside their unequal sample sizes. Pathway summaries combine expression across gene sets; sensitivity checks examine whether the same data support similar conclusions under altered analytical choices.

| Input or source | Role in this case | Source context |
| --- | --- | --- |
| [GEO GSE15641](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE15641) | Historical renal tumor microarray cohort and deposited labels; preserve dataset/study attribution. | Retain attribution and source terms; this README grants no additional reuse rights |
| [GEO GPL96](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GPL96) | Probe annotation; historical mappings are not current transcript-specific certification. | Retain attribution and source terms; this README grants no additional reuse rights |
| [Original study](https://pubmed.ncbi.nlm.nih.gov/16115910/) | Label/study context, not independent pathology adjudication. | Retain attribution and source terms; this README grants no additional reuse rights |
| [MSigDB Hallmark collection](https://www.gsea-msigdb.org/gsea/msigdb/human/collections.jsp#H) | Hallmark v2025.1 human sets; consult MSigDB terms before redistribution. Exact selected GMT and provenance are in the package. | Retain attribution and source terms; this README grants no additional reuse rights |

## Recorded findings

| Subtype or contrast | Recorded sample or pattern | Interpretation |
| --- | --- | --- |
| Clear-cell | 22 tumors; higher hypoxia-related expression | Bulk expression summary, not direct hypoxia measurement. |
| Papillary | 11 tumors | Small subtype cohort. |
| Chromophobe | 6 tumors; higher oxidative-phosphorylation expression | Gene-set expression does not establish pathway flux. |
| Sensitivity-stable pathway counts | 1 / 16 / 7 across the three contrasts | Counts surviving the stated analytical checks. |

The primary cohort has 39 samples: 22 clear-cell, 11 papillary and six chromophobe. Ten ambiguously coded clear-cell samples are excluded from the primary analysis and included in an all-49 sensitivity. Log2(signal+1), quantile normalization and probe collapsing yield 10,947 genes. Global BH families contain 32,841 gene tests and 150 pathway tests. Clear-cell/papillary, clear-cell/chromophobe and papillary/chromophobe significant gene counts are 2,897/2,695/1,809; main significant pathway counts are 19/26/23. Counts surviving all three stated sensitivities with stable direction and LOO sign are 1/16/7. The supported broad pattern is higher hypoxia-related expression in clear-cell and higher oxidative-phosphorylation expression in chromophobe.

The original session records scientific execution and repeatability checks; this local preparation does not re-execute them. Scientific artifacts included in this selected export:

These files are within session.science and its embedded archive; they are not separate files alongside this README. No empty inputs/expected/outputs/attachments directories or duplicate extracted datasets are created.

## What the comparison shows

The recurring hypoxia and oxidative-phosphorylation patterns provide biological context. Their stability within this dataset does not establish a subtype diagnostic test or direct pathway activity.

## Assumptions and limits

The small, historical bulk-tissue cohort lacks independently reassessed pathology, patient linkage, batch, purity and treatment information. Pathway scores summarize relative expression rather than biochemical activity. Reused-sample sensitivity checks do not establish causal mechanisms, diagnostic accuracy or clinical biomarkers.

## Sources and research materials

The unchanged research package comes from the [upstream archive](https://huggingface.co/datasets/AIPOCH-AI/open-science-cases/tree/4a22011b2b0d08492b55d75798ecb29acbeba32c/cases/case7). It retains the original conversation and included scientific artifacts, including analysis code, results and figures. The poster is an AI-generated thematic illustration, not study evidence. This introduction summarizes archived findings; the analysis was not rerun. Later bounded checks do not certify the entire study or mean the original package was corrected.
